Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capmatinib vs spartalizumab vs docetaxel in cancer (Japan, Phase 2)
jRCT2080224545Phase 2Completed
- Start
- Feb 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2 trial of capmatinib, spartalizumab and docetaxel in cancer (3 arms). Started Feb 2019; status: completed.
02
Drugs
capmatinibspartalizumabdocetaxel
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224545.